Impact Biomedical, Stock Today
| IBO Stock | USD 1.93 0.20 11.56% |
Performance7 of 100
| Odds Of DistressLess than 46
|
Impact BioMedical, is selling at 1.93 as of the 7th of January 2025; that is 11.56% up since the beginning of the trading day. The stock's open price was 1.73. Impact BioMedical, has 46 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. The performance scores are derived for the period starting the 8th of December 2024 and ending today, the 7th of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 16th of September 2024 | Category Healthcare | Classification Health Care |
Impact BioMedical, is entity of United States. It is traded as Stock on NYSE MKT exchange. The company has 11.5 M outstanding shares of which 1.05 K shares are currently shorted by investors with about 0.02 days to cover. More on Impact BioMedical,
Moving against Impact Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Impact Stock Highlights
| Chairman CEO | JD Esq | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Health Care (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Impact BioMedical, can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Impact BioMedical,'s financial leverage. It provides some insight into what part of Impact BioMedical,'s total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Impact BioMedical, (IBO) is traded on NYSE MKT Exchange in USA. It is located in 1400 Broadfield Blvd., Houston, TX, United States, 77084 and employs 1 people. Impact BioMedical, is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 19.9 M. Impact BioMedical, runs under Biotechnology sector within Health Care industry. The entity has 11.5 M outstanding shares of which 1.05 K shares are currently shorted by investors with about 0.02 days to cover.
Impact BioMedical, generates negative cash flow from operations
Check Impact BioMedical, Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Impact BioMedical, is $19.9 Million. Impact BioMedical, secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Impact Ownership Details
Impact BioMedical, Historical Income Statement
Impact Stock Against Markets
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical,. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical, is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical,'s value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical,'s market value can be influenced by many factors that don't directly affect Impact BioMedical,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.